Edesa Biotech, Inc.
Datakwaliteit: 83%
EDSA
Nasdaq
Manufacturing
Chemicals
€ 6,05
▲
€ 0,09
(1,51%)
Marktkapitalisatie: 50,51 M
Prijs
€ 6,05
Marktkapitalisatie
50,51 M
Dagbereik
€ 5,70 — € 6,25
52-Weeksbereik
€ 0,72 — € 9,37
Volume
158.512
Openen € 5,86
50D / 200D Gem.
€ 3,60
68,29% above
50D / 200D Gem.
€ 2,45
147,04% above
Quick Summary
Belangrijkste Punten
Negative free cash flow of -7,89 M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-55,66%
Onder sectorgemiddelde (-53,41%)
ROIC-47,00%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio16,82
Interest CoverageN/A
Waardering
PE (TTM)
-6,46
Onder sectorgemiddelde (-1,48)
P/B Ratio3,62
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -6,5 | -1,5 |
| P/B | 3,6 | 1,6 |
| ROE % | -55,7 | -53,4 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -7,82 M |
| ROE | -55,66% | ROA | -52,96% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -7,89 M |
| ROIC | -47,00% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 16,82 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 11,96 M | Tangible Book Value | 12,00 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -6,46 | Forward P/E | N/A |
| P/B Ratio | 3,62 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -15,63% | ||
| Market Cap | 50,51 M | Enterprise Value | 38,41 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | N/A |
| FCF / Share | -0,95 | OCF / Share | -0,95 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 100,98% |
| SBC-Adj. FCF | -8,62 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | 0,0 |
| Net Income | -7,19 M | -6,17 M | -8,37 M | -17,55 M | -13,34 M |
| EPS (Diluted) | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -7,91 M | -7,01 M | -9,22 M | -18,37 M | -23,68 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 3,67 M | 2,88 M | 4,79 M | 13,34 M | 17,95 M |
| SG&A Expenses | — | — | — | — | — |
| D&A | 119.273,0 | 186.049,0 | 183.471,0 | 118.188,0 | 118.788,0 |
| Interest Expense | — | — | — | — | — |
| Income Tax | 800,0 | 800,0 | 800,0 | 800,0 | 800,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 13,53 M | 3,81 M | 8,89 M | 11,58 M | 14,58 M |
| Total Liabilities | — | 1,83 M | 1,84 M | 2,18 M | 1,53 M |
| Shareholders' Equity | 12,45 M | 1,98 M | 7,05 M | 9,39 M | 13,06 M |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 10,80 M | 1,00 M | 5,40 M | 7,09 M | 7,84 M |
| Current Assets | 11,51 M | 1,68 M | 6,44 M | 9,09 M | 12,09 M |
| Current Liabilities | 1,08 M | 1,83 M | 1,82 M | 2,14 M | 1,46 M |
{"event":"ticker_viewed","properties":{"ticker":"EDSA","listing_kind":"stock","pathname":"/stocks/edsa","exchange":"Nasdaq","country":"US"}}